Sheena Bhalla
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 15
- COVID-19 and healthcare impacts 7
- Cancer Immunotherapy and Biomarkers 5
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Deborah B. Doroshow (4 shared papers)Fred R. Hirsch (3 shared papers)Lynette Marie Sholl (1 shared paper)Mary Beth Beasley (1 shared paper)David L. Rimm (1 shared paper)Ignacio Ivan Wistuba (1 shared paper)Ming‐Sound Tsao (1 shared paper)Sacha Gnjatic (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of the National Comprehensive Cancer Network (2 papers)Clinical Lung Cancer (2 papers)Lung Cancer (2 papers)British Journal of Ophthalmology (1 paper)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Sheena Bhalla
32 papers receiving 1.8k citations
Sheena Bhalla's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 855
- Immunology 380
- Internal Medicine 42
- Infectious Diseases 213
- Cancer Research 133
Countries citing papers authored by Sheena Bhalla
This map shows the geographic impact of Sheena Bhalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheena Bhalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheena Bhalla more than expected).
Fields of papers citing papers by Sheena Bhalla
This network shows the impact of papers produced by Sheena Bhalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheena Bhalla. The network helps show where Sheena Bhalla may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheena Bhalla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-L1 as a biomarker of response to immune-checkpoint inhibitors Hit paper breakdown → | 2021 | 1175 |
| 2 | 2020 | 121 | |
| 3 | 2020 | 94 | |
| 4 | 2020 | 74 | |
| 5 | 2020 | 61 | |
| 6 | 2023 | 35 | |
| 7 | 2020 | 33 | |
| 8 | 2013 | 30 | |
| 9 | 2023 | 30 | |
| 10 | 2022 | 22 | |
| 11 | 2019 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2024 | 11 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2025 | 9 | |
| 18 | Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies. | 2018 | 7 |
| 19 | Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia. | 2018 | 7 |
| 20 | 2023 | 7 |
About Sheena Bhalla
Sheena Bhalla is a scholar working on Oncology, Hematology, Genetics, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Phagocytosis and Immune Regulation (3 papers). The work is most often cited by research in Oncology (855 citations), Immunology (380 citations), Internal Medicine (42 citations), Infectious Diseases (213 citations) and Cancer Research (133 citations). Sheena Bhalla has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Deborah B. Doroshow, Fred R. Hirsch, Lynette Marie Sholl, Mary Beth Beasley, David L. Rimm, Ignacio Ivan Wistuba, Ming‐Sound Tsao, Sacha Gnjatic, Keith M. Kerr and David E. Gerber. Their work appears in journals such as Annals of Oncology, Journal of the National Comprehensive Cancer Network, Clinical Lung Cancer, Lung Cancer and British Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.